1,225 followers
296 followers
RT @FrontImmunol: New Research: Adjuvant therapy provides no additional recurrence-free benefit for esophageal squamous cell carcinoma pati…
33,075 followers
New Research: Adjuvant therapy provides no additional recurrence-free benefit for esophageal squamous cell carcinoma patients after neoadjuvant chemoimmunotherapy and surgery: a multi-center propensity score match study: Purpose The need for… https://t.co